Novel sodium-ion battery is an environmentally friendly, economic and efficient solution for a variety of applications including electric vehicles and stationary storage for renewable energies
Yissum presents new oxidation-resistant copper nano-inks with a low sintering temperature (lower than 150oC), which enables the printing of low-cost conductive patterns on heat sensitive plastic substrates. Due to these traits, the new inks, developed by Prof. Shlomo Magdassi, from the Institute of Chemistry and the Center for Nanoscience and Nanotechnology can be tailored for a variety of applications, including ink-jet, flexography and screen printing.
The technology uses certain bacteria as novel bio-filters to reduce nitrate levels in both fresh-water and sea-water aquariums.
The novel polymer-clay composites have a higher pollutant removal capacity in comparison to activated carbon (the most common sorbent). The technology will be presented at the WATEC Conference, to be held in Tel Aviv, Israel on October 22-24, 2013.
The announcement was made at the opening of the new site of Qlight at the Edmond J. Safra Givat Ram Campus of the Hebrew University of Jerusalem in the presence of a senior management delegation from Merck headed by Dr. Bernd Reckmann, Member of the Executive Board, and in the presence of Mr. Nir Barkat, Mayor of Jerusalem, and Prof. Ben-Sasson , Hebrew University President and other dignitaries. [Hebrew PR]
The invention is based on a machine-learning algorithm that predicts the next outgoing call.
Novel biocontrol agent is environmentally-friendly, non-toxic and effective for a large variety of plants.
A novel method for detecting retinal micro-aneurysms that pose a high risk for leakage, an underlying cause of diabetic retinopathy. Diabetic retinopathy is a leading cause of blindness worldwide. The novel method will enable early diagnosis and treatment of the condition, potentially minimizing damage and saving vision.
In parallel, Holmen, a leading manufacturer in the forest based sector, has entered into an investment and sub-licensing agreement with Melodea, by which Holmen has become one of the major shareholders in Melodea.
The capital is intended for the on-going Phase II clinical trial of ladostigil, a novel molecule for treatment of mild cognitive impairment; interim analysis is expected in H1 2014
Yissum, introduces new chickpea varieties, which retain high nutritional values yet exhibit improved synchronization between flowering and the rainy season to increase yield. The new varieties were developed by Professor Shahal Abbo, The Robert H. Smith Institute of Plant Sciences and Genetics in Agriculture, Robert H. Smith Faculty of Agriculture, Food and Environment at the Hebrew University.
Results showing the effectiveness of the vaccine in dogs were recently published in the journal Vaccine
Integra Holdings closes U.S. $ 7.0 million private financing
Novel biocontrol agent is environmentally-friendly, non-toxic and effective for a large variety of plants
The novel method uses a peptide derived from HIV to increase the sensitivity of cancer cells to radiotherapy and chemotherapy
Yaacov Michlin appointed Chairman of the Board and Dr. Yona Geffen appointed Chief Executive Officer
Technology, to be presented at Agritech Israel 2012, enables better control over fish reproduction cycle, increasing spawning and fish size
Yissum, the research and development company of the Hebrew University of Jerusalem, North Carolina State University, Raleigh , N.C., and Dow AgroFresh, a business unit of Rohm and Haas Company, a wholly owned subsidiary of The Dow Chemical Company, signed a license agreement for the development and commercialization of a novel water-soluble ethylene-antagonist for agricultural applications.
The work was published in the latest issue of the prestigious Nature Biotechnology journal
Atox Bio will be included as one of the portfolio companies of Integra Holdings, a holding company currently formed by Yissum, the technology transfer company of the Hebrew University of Jerusalem.